Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. (Q44074134)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. |
scientific article |
Statements
Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial (English)
F Follath
H Just
J G Y Papp
H Scholz
K Peuhkurinen
V P Harjola
V Mitrovic
M Abdalla
E-P Sandell
L Lehtonen
Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study